Annual SGA
$4.19 M
-$770.10 K-15.52%
December 31, 2023
Summary
- As of February 26, 2025, LIXT annual SGA is $4.19 million, with the most recent change of -$770.10 thousand (-15.52%) on December 31, 2023.
- During the last 3 years, LIXT annual SGA has risen by +$2.15 million (+105.21%).
- LIXT annual SGA is now -15.88% below its all-time high of $4.98 million, reached on December 31, 2021.
Performance
LIXT SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$621.60 K
-$176.80 K-22.14%
September 30, 2024
Summary
- As of February 26, 2025, LIXT quarterly SGA is $621.60 thousand, with the most recent change of -$176.80 thousand (-22.14%) on September 30, 2024.
- Over the past year, LIXT quarterly SGA has stayed the same.
- LIXT quarterly SGA is now -57.72% below its all-time high of $1.47 million, reached on June 30, 2021.
Performance
LIXT Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$199.85 M
-$4.00 M-2.04%
September 30, 2024
Summary
- As of February 26, 2025, LIXT TTM SGA is -$199.85 million, with the most recent change of -$4.00 million (-2.04%) on September 30, 2024.
- Over the past year, LIXT TTM SGA has dropped by -$202.99 million (-6455.30%).
- LIXT TTM SGA is now -572532.38% below its all-time high of -$34.90 thousand.
Performance
LIXT TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
LIXT Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -15.5% | 0.0% | -6455.3% |
| 3 y3 years | +105.2% | -50.0% | -4256.0% |
| 5 y5 years | +99.9% | -50.0% | -4256.0% |
LIXT Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -15.9% | at low | -55.0% | at low | -44.8% | at low |
| 5 y | 5-year | -15.9% | +154.2% | -57.7% | +204.7% | -91.0% | at low |
| alltime | all time | -15.9% | >+9999.0% | -57.7% | +924.4% | <-9999.0% | at low |
Lixte Biotechnology Holdings Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $621.60 K(-22.1%) | $3.14 M(-7.9%) |
| Jun 2024 | - | $798.40 K(-5.8%) | $3.41 M(-11.5%) |
| Mar 2024 | - | $847.80 K(-3.3%) | $3.86 M(-8.0%) |
| Dec 2023 | $4.19 M(-15.5%) | $876.80 K(-1.7%) | $4.19 M(-6.7%) |
| Sep 2023 | - | $891.70 K(-28.2%) | $4.49 M(-6.5%) |
| Jun 2023 | - | $1.24 M(+5.2%) | $4.81 M(-2.8%) |
| Mar 2023 | - | $1.18 M(+0.2%) | $4.95 M(-0.3%) |
| Dec 2022 | $4.96 M(-0.4%) | $1.18 M(-2.2%) | $4.96 M(-0.8%) |
| Sep 2022 | - | $1.21 M(-12.7%) | $5.00 M(+4.1%) |
| Jun 2022 | - | $1.38 M(+15.5%) | $4.81 M(-1.8%) |
| Mar 2022 | - | $1.20 M(-2.1%) | $4.90 M(-1.7%) |
| Dec 2021 | $4.98 M(+144.0%) | $1.22 M(+20.9%) | $4.98 M(+11.9%) |
| Sep 2021 | - | $1.01 M(-31.3%) | $4.46 M(+4.9%) |
| Jun 2021 | - | $1.47 M(+14.7%) | $4.25 M(+40.1%) |
| Mar 2021 | - | $1.28 M(+85.1%) | $3.03 M(+48.4%) |
| Dec 2020 | $2.04 M(+23.9%) | $692.60 K(-13.7%) | $2.04 M(+31.4%) |
| Sep 2020 | - | $802.30 K(+214.1%) | $1.55 M(+22.8%) |
| Jun 2020 | - | $255.40 K(-12.7%) | $1.27 M(-18.8%) |
| Mar 2020 | - | $292.50 K(+43.4%) | $1.56 M(-5.9%) |
| Dec 2019 | $1.65 M(-21.4%) | $204.00 K(-60.3%) | $1.66 M(-9.7%) |
| Sep 2019 | - | $513.80 K(-6.2%) | $1.83 M(-22.0%) |
| Jun 2019 | - | $547.80 K(+40.3%) | $2.35 M(+10.2%) |
| Mar 2019 | - | $390.40 K(+2.3%) | $2.13 M(+1.7%) |
| Dec 2018 | $2.10 M(+56.2%) | $381.50 K(-63.0%) | $2.10 M(+2.6%) |
| Sep 2018 | - | $1.03 M(+211.6%) | $2.05 M(+60.8%) |
| Jun 2018 | - | $330.80 K(-6.6%) | $1.27 M(+4.4%) |
| Mar 2018 | - | $354.10 K(+7.5%) | $1.22 M(-9.2%) |
| Dec 2017 | $1.34 M(+6.1%) | $329.30 K(+27.9%) | $1.34 M(-2.6%) |
| Sep 2017 | - | $257.50 K(-7.1%) | $1.38 M(-3.7%) |
| Jun 2017 | - | $277.30 K(-41.9%) | $1.43 M(+2.8%) |
| Mar 2017 | - | $477.40 K(+30.6%) | $1.39 M(+30.5%) |
| Dec 2016 | $1.26 M(+67.7%) | $365.60 K(+17.5%) | $1.07 M(+27.0%) |
| Sep 2016 | - | $311.10 K(+30.7%) | $840.10 K(+22.8%) |
| Jun 2016 | - | $238.10 K(+56.5%) | $684.30 K(+3.7%) |
| Mar 2016 | - | $152.10 K(+9.6%) | $659.90 K(-12.5%) |
| Dec 2015 | $754.40 K | $138.80 K(-10.6%) | $754.40 K(-22.5%) |
| Sep 2015 | - | $155.30 K(-27.3%) | $973.90 K(-3.7%) |
| Jun 2015 | - | $213.70 K(-13.3%) | $1.01 M(+3.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2015 | - | $246.60 K(-31.2%) | $978.80 K(-23.8%) |
| Dec 2014 | $1.29 M(+159.6%) | $358.30 K(+86.3%) | $1.29 M(+23.4%) |
| Sep 2014 | - | $192.30 K(+5.9%) | $1.04 M(+10.5%) |
| Jun 2014 | - | $181.60 K(-67.2%) | $942.00 K(+7.0%) |
| Mar 2014 | - | $553.00 K(+384.2%) | $880.40 K(+77.9%) |
| Dec 2013 | $495.00 K(-54.7%) | $114.20 K(+22.5%) | $495.00 K(-6.4%) |
| Sep 2013 | - | $93.20 K(-22.3%) | $528.80 K(-39.9%) |
| Jun 2013 | - | $120.00 K(-28.4%) | $880.10 K(-6.7%) |
| Mar 2013 | - | $167.60 K(+13.2%) | $942.90 K(-13.8%) |
| Dec 2012 | $1.09 M(+105.0%) | $148.00 K(-66.7%) | $1.09 M(-3.3%) |
| Sep 2012 | - | $444.50 K(+143.2%) | $1.13 M(+37.7%) |
| Jun 2012 | - | $182.80 K(-42.6%) | $821.40 K(+7.8%) |
| Mar 2012 | - | $318.30 K(+71.7%) | $762.20 K(+42.9%) |
| Dec 2011 | $533.40 K(+22.3%) | $185.40 K(+37.4%) | $533.50 K(+95.6%) |
| Sep 2011 | - | $134.90 K(+9.1%) | $272.70 K(-28.9%) |
| Jun 2011 | - | $123.60 K(+37.9%) | $383.80 K(+13.9%) |
| Mar 2011 | - | $89.60 K(-218.8%) | $337.10 K(-22.7%) |
| Dec 2010 | $436.10 K(-58.6%) | -$75.40 K(-130.7%) | $436.10 K(-56.8%) |
| Sep 2010 | - | $246.00 K(+219.9%) | $1.01 M(-5.2%) |
| Jun 2010 | - | $76.90 K(-59.2%) | $1.06 M(-2.3%) |
| Mar 2010 | - | $188.60 K(-62.1%) | $1.09 M(+3.4%) |
| Dec 2009 | $1.05 M(+58.6%) | $497.90 K(+65.5%) | $1.05 M(+55.3%) |
| Sep 2009 | - | $300.90 K(+195.6%) | $678.60 K(-3.2%) |
| Jun 2009 | - | $101.80 K(-33.5%) | $701.20 K(+27.8%) |
| Mar 2009 | - | $153.10 K(+24.7%) | $548.50 K(-17.4%) |
| Dec 2008 | $664.20 K(-46.2%) | $122.80 K(-62.0%) | $664.20 K(-0.4%) |
| Sep 2008 | - | $323.50 K(-735.6%) | $667.00 K(-44.3%) |
| Jun 2008 | - | -$50.90 K(-118.9%) | $1.20 M(-11.5%) |
| Mar 2008 | - | $268.80 K(+114.0%) | $1.35 M(+6.8%) |
| Dec 2007 | $1.23 M(+359.0%) | $125.60 K(-85.3%) | $1.27 M(+4.8%) |
| Sep 2007 | - | $853.10 K(+718.7%) | $1.21 M(+187.5%) |
| Jun 2007 | - | $104.20 K(-43.0%) | $420.10 K(-2.3%) |
| Mar 2007 | - | $182.80 K(+169.6%) | $429.80 K(+59.8%) |
| Dec 2006 | $269.00 K(+717.6%) | $67.80 K(+3.8%) | $269.00 K(+33.7%) |
| Sep 2006 | - | $65.30 K(-42.7%) | $201.20 K(+48.1%) |
| Jun 2006 | - | $113.90 K(+417.7%) | $135.90 K(+517.7%) |
| Mar 2006 | - | $22.00 K | $22.00 K |
| Dec 2005 | $32.90 K | - | - |
FAQ
- What is Lixte Biotechnology Holdings annual SGA?
- What is the all time high annual SGA for Lixte Biotechnology Holdings?
- What is Lixte Biotechnology Holdings annual SGA year-on-year change?
- What is Lixte Biotechnology Holdings quarterly SGA?
- What is the all time high quarterly SGA for Lixte Biotechnology Holdings?
- What is Lixte Biotechnology Holdings quarterly SGA year-on-year change?
- What is Lixte Biotechnology Holdings TTM SGA?
- What is the all time high TTM SGA for Lixte Biotechnology Holdings?
- What is Lixte Biotechnology Holdings TTM SGA year-on-year change?
What is Lixte Biotechnology Holdings annual SGA?
The current annual SGA of LIXT is $4.19 M
What is the all time high annual SGA for Lixte Biotechnology Holdings?
Lixte Biotechnology Holdings all-time high annual SGA is $4.98 M
What is Lixte Biotechnology Holdings annual SGA year-on-year change?
Over the past year, LIXT annual SGA has changed by -$770.10 K (-15.52%)
What is Lixte Biotechnology Holdings quarterly SGA?
The current quarterly SGA of LIXT is $621.60 K
What is the all time high quarterly SGA for Lixte Biotechnology Holdings?
Lixte Biotechnology Holdings all-time high quarterly SGA is $1.47 M
What is Lixte Biotechnology Holdings quarterly SGA year-on-year change?
Over the past year, LIXT quarterly SGA has changed by $0.00 (0.00%)
What is Lixte Biotechnology Holdings TTM SGA?
The current TTM SGA of LIXT is -$199.85 M
What is the all time high TTM SGA for Lixte Biotechnology Holdings?
Lixte Biotechnology Holdings all-time high TTM SGA is -$34.90 K
What is Lixte Biotechnology Holdings TTM SGA year-on-year change?
Over the past year, LIXT TTM SGA has changed by -$202.99 M (-6455.30%)